Escolar Documentos
Profissional Documentos
Cultura Documentos
Group A3
August 8, 2016
Agenda
Section 1: Objectives
Section 2: Executive Summary
Objectives
What we were asked to do?
- FUTURE SCOPE
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
Agenda
Section 1: Objectives
Section 2: Executive Summary
Executive Summary
A quick glance on the data provided
TEST Group Data
Unique Physicians
829
MYRBETRIQ Rx Data for
months
Dec14 to Nov15
MYRBETRIQ Detailing Data for
months
Dec14 to Nov15
MYRBETRIQ Sampling Data for
months
Dec14 to Nov15
Market Brands Rx data for
months
Dec14 to Nov15
Physician Identifier- IMS ID
Other identifiers available:
Oabdecile, STATE, Target Flag,
Specialty Group
Test Group
Data
Control Group
Data
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
Executive Summary
A quick glance on the Analysis done
Rx_Myrbetriq
800
Post-Campaign
Pre-Campaign
700
718.00
600
683.00
585.00
563.00
582.00
499.00
500
462.00
Rx
406.00
492.00
400
Test Post
Campaign
589.00
397.00
438.00
459.00
502.00
470.00
529.00
447.00
523.00
2786
457.00
386.00
429.00
453.00
IMPACT MEASUREMENT
Test Pre
2927
Campaign
446.00
398.00
141
3001
198
IMPACT=A-B
-57
300
200
100
0
Dec'14
Jan'15
Feb'15
Mar'15
Apr'15
May'15
Jun'15
Jul'15
Aug'15
Sep'15
Oct'15
Nov'15
Month
test
c3
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
Agenda
Section 1: Objectives
Section 2: Executive Summary
Myrbetriq wants to know the effect of a digital marketing campaign for its drug.
To study the effect, a group of physicians is targeted for this campaign.
Test group is exposed to the campaign. Besides the effect of campaign, there should not
be any difference in the behavior of test and control group.
Out of given control groups, the control group which replicates the behavior of the test
group during the pre-campaign period, most closely, needs to be identified.
Impact of the campaign is to be calculated by taking the selected control group as the
base.
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly Restricted
Agenda
Section 1: Objectives
Section 2: Executive Summary
ASSUMPTIONS
DATA CLEANING
SEGMENTATION
Categorizing Decile into 3
categories-
H: 8-10,
M: 4-7 and
L: 1-3
Categorizing the States into 4
regions:
Midwest
West
North-East
South
Unique ID using Decile, Specialty
Group and Region.
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
10
Agenda
Section 1: Objectives
Section 2: Executive Summary
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
12
Continued
Amongst the 3 given control groups, the control group most closely representing test group is selected
Average_Rx_Market
Average_Rx_Myrbetriq
60
20
45.71
43.62
41.76
40
10
16.52
13.74
12.54
7.34
20.37
18.43
14.23
8.24
6.31
7.37
0
obg
5.00
6.92
7.59
6.96
0.75
other
pcp
urology
15.97
14.42352941
14.09
14
30
20
17.44
16
Average_Rx
Average_Rx
18
48.49
50
12
10
8 5.17
6
5.54
3.48
7.12
5.40
5.50
4.28
2.49
2.11
2
2.05
0
obg
other
Specialty Group
test
c1
c2
1.27
0.86
1.95 1.93
0.75
pcp
1.43
0.82
urology
Specialty Group
c3
test
c1
c2
c3
From the above graphs and by calculating Euclidean's Distance , we conclude that Control Group 3 is closest to test on the
basis of specialty group.
Refer Annexure for Euclidean Distance Calculation.
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
13
Continued
Amongst the 3 given control groups, the control group most closely representing test group is selected
Average_Rx_Market
Average_Rx_Myrbetriq
25
6.08
19.08
18.62
18.21
15
14.95
14.42
15.43
13.87
10
9.69
10.79
5.93
5.81
16.39
15.87
11.30
10.68
10.00
10.07
7.89
Average_Rx
Average_Rx
20
5.36
5.23
4.34
4.52
4
3.56
4.034.08
3.80
3.73
3.14
3.12
2.97
2.35
5
1
0
0
SOUTH
MID WEST
NORTH EAST
WEST
SOUTH
MID WEST
Region
TEST
C1
NORTH EAST
WEST
Region
C2
C3
TEST
C1
C2
C3
From the above graphs and by calculating Euclidean's Distance , we conclude that Control Group 3
is closest to test on the basis of Region
For Euclideans Distance Calculation, refer to annexure
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
14
Agenda
Section 1: Objectives
Section 2: Executive Summary
35%
374
45%
525
No Cut-Off
814
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
16
Post-Campaign
Pre-Campaign
0.88
0.8
0.84
0.72
0.69
Average_Rx
0.7
0.61
0.57
0.6
0.50
0.60
0.5
0.4
0.71
0.49
0.54
0.56
Feb'15
Mar'15
0.56
0.62
0.58
0.65
0.55
0.64
0.72
0.56
0.47
0.53
0.49
0.55
0.3
0.2
0.1
0
Dec'14
Jan'15
Apr'15
May'15
Jun'15
Jul'15
Aug'15
Sep'15
Oct'15
Nov'15
Month
c3
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
17
0.63
0.49
0.5
0.45
0.46
0.41
Average_Rx
Post-Campaign
Pre-Campaign
0.6
0.43
0.58
0.53
0.59
0.47
0.49
0.48
0.47
0.48
0.4
0.39
0.45
0.46
0.40
0.37
0.35
0.2
0.1
0
Dec'14
Jan'15
Feb'15
Mar'15
Apr'15
May'15
Jun'15
Jul'15
Aug'15
Sep'15
Oct'15
Month
0.50
0.41
0.39
0.3
0.63
Nov'15
c3
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
18
No ERROR CUT-OFF
Average_Rx_Myrbetriq
0.6
Post-Campaign
Pre-Campaign
0.5
0.41
0.40
0.4
Average_Rx
0.41
0.45
0.36
0.32
0.33
0.28
0.29
Dec'14
Jan'15
0.37
0.35
0.34
0.38
0.3
0.47
0.45
0.44
0.49
0.30
0.34
0.31
0.35
0.36
0.31
0.30
0.2
0.1
0
Feb'15
Mar'15
Apr'15
May'15
Jun'15
Month
test
Jul'15
Aug'15
Sep'15
Oct'15
Nov'15
c3
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
19
4.5
4
Average
3.5
3
2.5
2
1.58
1.54
1.5
1
0.5
0
Sampling
Detailing
Test
C3
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
20
Agenda
Section 1: Objectives
Section 2: Executive Summary
Specialty
Target %
Test %
OBG
3%
1%
UROLOGY
9%
6%
87%
92%
1%
1%
PCP
OTHERS
Region
MID WEST
NORTH EAST
SOUTH
WEST
Target %
28%
14%
41%
17%
Test %
27%
15%
42%
15%
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
22
Agenda
Section 1: Objectives
Section 2: Executive Summary
Post-Campaign
Pre-Campaign
700
Test Post
Campaign
718.00
600
683.00
585.00
563.00
462.00
Rx
406.00
492.00
400
457.00
3001
446.00
198
IMPACT=A-B
-57
589.00
500
397.00
438.00
459.00
502.00
470.00
529.00
447.00
523.00
386.00
429.00
453.00
2786
582.00
499.00
IMPACT MEASUREMENT
Test Pre
2927
Campaign
141
398.00
300
200
100
0
Dec'14
Jan'15
Feb'15
Mar'15
Apr'15
May'15
Jun'15
Month
test
c3
Jul'15
Aug'15
Sep'15
Oct'15
Nov'15
Test
26
27.6
Control
31.6
31.2
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly
Restricted
24
Agenda
Section 1: Objectives
Section 2: Executive Summary
Further Insights
What more could have been done?
The Null values could have been replaced by its decile averages.
Instead of choosing from 3 groups, an entire new group can be created from
the combined pool of 3 which will have better matching characteristics
The deciling can be done on the basis of detailing and sample drops and take
them as categorical variable.
During the error calculation process, weights can be assigned to different
parameters.
During error calculation, small changes resulting in large error can be avoided
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly Restricted
26
Agenda
Section 1: Objectives
Section 2: Executive Summary
Annexure
Writing on Basis of Specialty Group
Market
obg
urology
pcp
other
Euclidean
Distance
test
7.344828
41.76056
6.955556
0.75
2.054054
c1
12.53968
48.49333
7.588435
20.37209
6.918033
c2
16.51852
43.61875
8.239796
18.42857
5
c3
13.74074
45.71176
7.365108
14.22642
6.311475
Myrbetriq
test
c1
c2
c3
obg
3.482759 5.396825 5.537037 5.166667
urology 17.43662 15.97333 14.09375 14.42353
pcp
2.111111 1.926871 2.494898 1.947842
other
0.75
7.116279
5.5
4.283019
1.27027 1.42623 0.857143 0.819672
Euclidean
Distance
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly Restricted
28
Annexure
Writing on Basis of Region
Myrbetriq
SOUTH
TEST
C1
C2
C3
Market
5.929293
4.029536
Euclidean
Distance
2.93458812
9
3.011585
4.519774
3.142077
2.627014
TEST
C1
18.620915
SOUTH
9.694864
03
14.419847
MID WEST 10.7897
33
NORTH
16.389312
EAST
10
98
10.684466
WEST
7.891304
02
Euclidean
11.894428
Distance
0
58
C2
C3
19.08333
18.20539
13.86957
14.94515
15.87059
15.42938
10.06667
11.29508
11.69722
11.43506
Copyright 2016 Axtria and/or its affiliates. All rights reserved. | Axtria Confidential Internal/Restricted/Highly Restricted
29